Allurion Technologies Inc Key Metrics
Default
All financials are in USD Million and price data in USD
VIEW MORE
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Check Before You Buy
VIEW FULL CHECKLISTLow rank
5Positive12Negative
29.4% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
Allurion Technologies Inc Stock Price Analysis
Day Price Range | 3 (LTP) 2.73 LowHigh |
Week Price Range | 3 (LTP) 2.24.2 LowHigh |
Month Price Range | 3 (LTP) 2.24.2 LowHigh |
52 Week Price Range | 3 (LTP) 0.316.8 LowHigh |
Allurion Technologies Inc Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Hit
Allurion Technologies Inc's Revenue was higher than average estimate 1 time in past 1 year
EPS forecast
Current EPS
Avg. Estimate
Consensus Recommendation
4 ANALYST Recommendations
BUY
The consensus recommendation from 4 analysts for Allurion Technologies Inc is BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Allurion Technologies Inc Stock Analysis
Allurion Technologies Inc stock analysis with key metrics, changes, and trends.
| Allurion Technologies Inc Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
|---|---|---|---|---|---|
| Annual Revenue | $53.47 M | 16.73% | negative |
| |
| Annual Net Profit | $80.61 M | 113.56% | negative |
| |
| Price to Earning Ratio | -0.72 | - | negative |
| |
| Stock Price | $2.98 | 77.38% | positive |
| |
| Quarterly Revenue | $5.37 M | 70.51% | negative |
| |
| Quarterly Net profit | $9 M | 58.37% | positive |
| |
| Mutual Fund Holding | 1.99 % | -1.3% | negative |
| |
| Interest Coverage Ratio | -6.6 | - | negative |
| |
| Institutional Holding | 8.85 % | -5.81% | negative |
| |
Loading data..
Allurion Technologies Inc - Company Profile
What does Allurion Technologies Inc do?
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Allurion Technologies Inc Management structure
All Gross Remunerations are in USD